Crescent Biopharma (CBIO) Stock Price & Financial Analysis
Crescent Biopharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Crescent Biopharma
What is the current stock price for CBIO?
As of the latest trading session, CBIO stock trades at $17.36. The 52-week range is $8.72–$27.41, with a day range of $16.92–$17.80.
What is the P/E ratio for CBIO?
The P/E ratio (Price-to-Earnings) for CBIO is shown in the Key Statistics section. This valuation metric helps compare Crescent Biopharma, Inc. to industry peers.
Does CBIO pay dividends?
Crescent Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CBIO?
Based on 7 analysts, the consensus for CBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CBIO?
Crescent Biopharma's market capitalization is $527.7M, classifying it as a small-cap company. Crescent Biopharma operates in the Healthcare sector within the Biotechnology industry.